Recent studies have provided evidence for human salivary proline-rich proteins (PRPs) serving as potential receptors in the acquired pellicle for Actinomyces viscosus type 1 fimbriae. We report here the isolation of mutants derived from A. viscosus T14V-J1 which are defective in binding to PRPs partially purified from parotid gland saliva. Mutagenesis with ethyl methanesulfonate preceded enrichment for cells nonreactive with PRPs by successive adsorptions with PRP-treated latex beads. Screening was accomplished by random selection of 250 isolated colonies from each of four enrichment cycles and reaction with PRP-treated latex beads in microtiter plates. Two mutants of independent origin were examined for adherence to hydroxyapatite treated with either PRPs, proline-rich glycoproteins, deglycosylated proline-rich glycoproteins, or whole saliva.
Actinomyces viscosus is a primary colonizer of human tooth surfaces and consequently is of central importance in dental plaque development. A. viscosus may be a significant factor in gingivitis (26) and periodontitis (19, 40) . One of the two antigenically and functionally distinct fimbrial types present on the surface of this bacterium, designated type 1, has been strongly implicated as having an essential role in the attachment of this organism to saliva-treated surfaces (10, 11) . Unlike the type 2 fimbriae of this organism, for which investigations have revealed a conventional lectincarbohydrate-like interaction between both these surface structures and receptors of certain streptococci (4) and neuraminidase-treated erythrocytes (12) , detailed studies at the molecular level of type 1 fimbrial interaction with specific salivary receptors are few.
Gibbons et al. (14, 15) have implicated acidic proline-rich proteins (PRPs) derived from parotid or submandibular saliva as promoting the attachment ofA. viscosus to apatitic surfaces. In addition, recent findings from our laboratory (22) , obtained by utilizing colloidal gold-labeled PRPs as probes in conjunction with fimbria-deficient mutants of A. viscosus (7) , lend further support to the proposed functional role of PRP binding to type 1 fimbriae. Clark et al. (9) have confirmed and extended these observations by using polystyrene as well as hydroxyapatite (HA) surfaces to examine the effect of various salivary proteins, including proline-rich glycoproteins (PRG), on the adsorptive behavior of A. viscosus T14V-J1 and fimbria-deficient mutants of this strain and have shown that rabbit polyclonal fimbria-specific antitype 1 immunoglobulin G and Fab fragments inhibit adsorp-tion of type 1-positive actinomyces to HA treated with PRPs and PRG. Recently, however, Cisar et al. (3) have reported that a panel of monoclonal antibodies to the type 1 fimbriae, which also react with the cloned subunit, failed to inhibit attachment ofA. viscosus T14V to saliva-treated HA (SHA) when tested in the adherence assay. One possibility to account for these results would provide for a fimbriaassociated molecule that is essential for adherence but is genetically and antigenically distinct from the fimbrial subunit.
In a further attempt to exanline the molecular nature of the binding of type 1 fimbriae of A. viscosus to PR]Ps, we have developed a method for the isolation of mutants of A. viscosus T14V-J1 which possess type 1 fimbriae and yet are deficient in their ability-to bind to pellicles of partially purified acidic PRPs. The results provide additional evidence for the hypothesis that A. viscosus possesses an adhesin that functions in association with type 1 fimbriae to mediate cell adsorption on salivary pellicles, but the adhesin may be genetically distinct from the fimbriae.
MATERIALS AND METHODS
Bacterial strains. A. viscosus T14V-J1, a streptomycinresistant isolate of strain T14V, was originally isolated as previously described (39) . This strain, which possesses both type 1 and type 2 fimbriae, was obtained from the culture collection at the University of Florida Periodontal Disease Research Center (College of Dentistry, University of Florida, Gainesville). Fimbria-deficient mutant strain 147, lacking both type 1 and type 2 fimbriae, and strain 5951, lacking only type 1 fimbriae, were derived from A. viscosus T14V-J1 as recently described (7) and were kindly provided by J. 0.
Cisar, National Institute of Dental Research. Streptococcus sanguis 34 was also provided by J. 0. Cisar. All strains were maintained as multiple frozen stocks in tryptic soy broth (TSB) (BBL, Cockeysville, Md.) containing 20% glycerol at -80°C. Unless otherwise indicated, all strains were grown aerobically in TSB overnight at 37°C. Defibrinated sheep blood-supplemented agar (Difco Laboratories, Detroit, Mich.) was used as the solid medium throughout this study. Antibiotic resistance was confirmed on Columbia CNA agar (BBL) containing 100 ,ug of streptomycin per ml.
Preparation of saliva and purification of saliva-derived molecules. Salivary acidic PRPs were partially purified as described recently (21) . PRG and deglycosylated PRG (dPRG) were also prepared by procedures described previously (24, 25, 28) and were generously provided by M. J. Levine, State University of New York, Buffalo. PRP-1 was kindly supplied by D. I. Hay, Forsyth, Boston, Mass. Whole saliva was collected in chilled containers and clarified by centrifugation at 12,000 x g for 10 min prior to treatment of the HA beads.
Latex bead preparation. Preparation of latex beads for enrichment was performed as described by Clark et al. (9) . Briefly, latex beads (particle diameter, 15.7 ,um) (Sigma Chemical Co., St. Louis, Mo.) were diluted 1:50 in the carbonate-bicarbonate buffer (pH 9.6) of Voller and Bidwell (36) , washed three times, and suspended to an optical density of 1.0 (A650) in the same buffer. The beads were divided into four aliquots and pelleted, and the supernatants were removed. Ten micrograms of PRPs (1 mg/ml) in the same buffer was added to each tube of beads and gently mixed for 2 h at room temperature prior to overnight storage at 4°C. Following one wash of the beads in adsorption buffer (50 mM KCl, 1 mM K2PO4, 1 mM CaCl2, 0.1 mM MgCl2), blocking buffer (adsorption buffer with 2 mg of bovine serum albumin [BSA] per ml) (Sigma) was added for 15 min to block unoccupied sites on the beads. Each aliquot of the bead suspension was transferred to separate 1.5-ml microcentrifuge tubes. The bead suspension was pelleted, and the supernatant was removed prior to addition of the bacterial suspension.
Ethyl methanesulfonate mutagenesis. An overnight culture of A. viscosus T14V-J1 was diluted 1:20 into fresh TSB and allowed to grow to mid-log phase. Ethyl methanesulfonate (Sigma) was added to 0.15 M, and the culture was vortexed briefly and incubated further for 1 h at 37°C. This time of exposure was long enough to allow for 10% survival. Cells were recovered by centrifugation and washed twice in phosphate-buffered saline (PBS), pH 7.0. The pellet was resuspended to 20 times the original volume in fresh TSB and grown overnight at 37°C to allow for expression of the mutation. Ten milliliters of the culture was removed, centrifuged, and washed twice in adsorption buffer. The cells were finally suspended to 5 x 108 to 5 x 109 CFU/ml in the same buffer prior to addition to the first tube of PRP-treated latex beads (PRP-LB).
Enrichment and screening. Enrichment proceeded by the addition of 1 ml of the cell suspension described above to a tube of PRP-LB. Sterility was maintained throughout the entire procedure. The tube was allowed to rotate at 4°C for 1 h, and the bead-cell suspension was pelleted for 15 s in a microcentrifuge. The beads were discarded following removal of the supernatant to a fresh tube of PRP-LB, and the enrichment cycle was repeated three times. Prior to each addition of the cell suspension to a fresh tube containing the latex bead preparation, 100 Scoring for aggregation was determined as described in Table 2 , footnote b.
Coaggregation assay. The coaggregation assay was performed as described previously (6 Adsorption of Adh-mutants to HA treated with saliva preparations. Binding of strains T14V-J1, 5951, 147, and the Adh-mutants to HA treated with various saliva preparations, as well as whole paraffin-stimulated saliva, is shown in Table 1 . Adsorption of the Adh-mutants GBOO7 and GBO18 to each of the experimental pellicles composed of salivary PRPs-PRP, PRG, and dPRG-was negligible (range, 0 to 10%), and adsorption to pellicles composed of whole saliva was only moderate (range, 28 to 31%); as measured by the Duncan multiple-range test, adsorption of the mutants was statistically significantly lower than that of the parent strain to these pellicles. The parent strain, T14V-J1, adsorbed well to HA treated with whole saliva (66%) and to PRP-treated HA (61%). Adsorption of the parent strain to dPRG (39%) was lower than that to whole saliva or PRP but was lowest for PRG-treated HA (27%). The fimbria-deficient mutant (strain 147) and strain 5951, like the Adh-mutants, adsorbed poorly to all pellicles (range, 0 to 18%).
Phenotypic characterization of Adh-mutants. The properties of the mutants isolated in this study were compared with those of the parent and fimbria-deficient strains. No differences in fermentation characteristics were noted when the parent strain, 5951, and fimbria-deficient strain 147 were compared with each of the mutants (34) .
The results shown in Table 2 reveal that both of the Adhmutants were capable of being agglutinated with both polyclonal antibody to type 1 fimbriae and monoclonal antibody to the type 1 fimbrial subunit, suggesting that the fimbrial structure was not significantly altered by the mutagenic treatment. Both mutants were also capable of being agglutinated with anti-type 2 antiserum, as well as able to coaggregate with S. sanguis 34. Neither of these mutants, however, was capable of being agglutinated by the adherence-inhibiting monoclonal antibody, 86-49E, even when concentrations as high as 10 ,ug of the antibody per ml were used. It should be noted that as little as 5 ,ug of this adherence-inhibiting monoclonal antibody per ml will inhibit adherence of the 
DISCUSSION
Successful colonization of the oral cavity often requires that a bacterium attach directly to host soft or hard tissue surfaces or to other organisms with the potential to interact with specific host components (17) . To begin to understand the molecular basis for colonization, it is necessary to identify the molecules present on the surface of organisms that allow for attachment to host-derived molecules. Fur- ther, those organisms capable of intergeneric coaggregation may have an additional means of establishing themselves in particular oral microenvironments (17) .
Although evidence from numerous studies has suggested that type 1 fimbriae are essential in the adherence of A.
viscosus to SHA (7, 10, 11) Intergeneric coaggregation of A. viscosus with other oral bacteria has been proposed as an important mechanism for the colonization of this organism in vivo (16, 17, 29) and has been shown to be dependent on the presence of type 2 fimbriae (5 
